BigBear.ai Holdings, Inc. (BBAI) - Due Diligence

hourglass

Loading…

Preparing the latest DD data, styles and content.

49NeutralDD: Jul 29, 2026Analyst: 46

paidPrice at analysis date

USD 2.80 (29/07/2026)

domainMkt cap

$1.34B

pie_chartShares

478.95M

candlestick_chart52W

$2.67-$9.39

trending_downShort interest

28.84%

MEDIUMNYSEIndustrials700 employeesFounded 2020

Verdict: Neutral — Catalyst-Driven, Elevated Risk —

Genuine defense/national security backlog ($281.9M, +14% QoQ) and a repaired balance sheet ($431M cash, near-zero debt after convertible conversion). But Q1 revenue was flat YoY, adj. EBITDA worsened to −$9.9M, an active securities class action is pending on the 2029 convertible notes restatement, and share count has ballooned +65.7% in 12 months. Stock sits at 52W low ($2.80 vs 52W high $9.39), price target average $5.00. Fair value $3.08/sh = +10% upside vs current $2.80. The whole thesis reprices on tomorrow's Q2 print.

📊 DIANALITICS RESEARCH INDEXCompany & Thesis Assessment Score /100 — updated 2026-07-29

BigBear.ai Holdings, Inc. (BBAI)

Defense & National Security AI · NYSE · McLean, VA

"Real backlog, repaired balance sheet, but flat revenue, active class action, and 65% dilution keep this speculative."

Backlog +14% QoQ $431M cash Q1 rev flat YoY Class action pending +65.7% share dilution YoY

Fin. strength

/20 pts

EBITDA/FCF

/15 pts

Debt/leverage

/15 pts

Stage/business

/15 pts

Catalysts

/10 pts

Reg. risk

/8 pts

Risk/reward

/7 pts

Management

/5 pts

Sector/macro

/3 pts

Compliance

/2 pts

💡 Fair Value Estimate — EV/Revenue forward (defense AI peer method)

Fair value base case

USD 3.08

Range: USD 1.90-USD 5.50

Price at analysis date: USD 2.80 (29/07/2026)

Base upside/downside: +10%

EV/Revenue forward is standard for pre-profit AI/defense. Implied EV/Sales at base FV = 5.75x (within ±4% of the 6.0x nominal). Cross-check via 2026E revenue × peer multiple confirms base FV within ±1%. Sensitivity to multiple is ±12.6% per 1x. Probability-weighted average: 0.25×$5.25 + 0.45×$3.10 + 0.30×$1.85 = $3.28 — 7% above base, reflecting the fat right tail from the short squeeze/DoD upside case. ⚠️ Not investment advice.

Component	Assumption	USD/share
Core business EV	2027E revenue $185M × 6.0x EV/Sales (peer median 6.5x, small discount for flat Q1) / 479M shares	+2.32
Cash & investments (Q1 2026)	$431.5M / 479M shares	+0.90
Residual debt (convertibles)	−$16.5M residual balance / 479M	−0.03
Class action reserve	Expected settlement $25M (restatement-type case) / 479M	−0.05
Cash burn haircut (2 yrs to profitability)	−$40M cumulative net burn 2026-27 haircut vs full cash value / 479M	−0.08
Ask Sage / GenAI platform option	20% probability × $150M option value (NASA/Army/NRL wins) / 479M	+0.06
Convertible tail dilution	Remaining ~$16M convertible expected settled in equity by end 2026 / 479M	−0.03
FV base case	Sum: 2.32 + 0.90 − 0.03 − 0.05 − 0.08 + 0.06 − 0.03	≈ $3.09

Bull

$5.00–5.50

Probability: 25%

Q2 beats consensus, management raises FY guidance, 2027 revenue lands at $220M+, adj. EBITDA turns positive H2 2027. Ask Sage GenAI platform wins additional DoD/IC contracts. Multiple expands to 10x fw on defense-AI premium. Short squeeze on 28.84% SI.

Base

$2.90–3.30

Probability: 45%

Q2 in-line, FY guide reaffirmed, backlog continues +10-15% QoQ growth, 2027 revenue $180-190M, adj. EBITDA improves but stays negative. Multiple holds at 6x fw. No re-rating either way.

Bear

$1.70–2.00

Probability: 30%

Q2 miss on revenue or adj. EBITDA further worsens, FY guide cut, class action settles at $50M+, 2027 revenue below $170M. DoD/IC contract awards slow. Multiple compresses to 3-4x, further dilutive raise possible if burn accelerates.

Methodology: EV/Revenue forward is standard for pre-profit AI/defense. Implied EV/Sales at base FV = 5.75x (within ±4% of the 6.0x nominal). Cross-check via 2026E revenue × peer multiple confirms base FV within ±1%. Sensitivity to multiple is ±12.6% per 1x. Probability-weighted average: 0.25×$5.25 + 0.45×$3.10 + 0.30×$1.85 = $3.28 — 7% above base, reflecting the fat right tail from the short squeeze/DoD upside case. ⚠️ Not investment advice. Not investment advice.

warning

🚨 Q2 2026 earnings TOMORROW (July 30) · active class action · massive dilution

Q2 2026 earnings release on 2026-07-30 (consensus: $36.4M revenue, EPS −$0.04) is the immediate binary catalyst. Additionally, a securities class action (Levi & Korsinsky, Rosen, Robbins) is pending re: material accounting error in 2029 Convertible Notes, restated 10-K FY2024, class period Mar 31, 2022 – Mar 25, 2025. Share count grew +65.7% YoY (much of it via convert-to-equity conversion that eliminated debt but crushed the equity). Short interest ~28.84%.

⚠️ Methodology note: Pre-profit defense/AI services company — EV/Revenue forward is the appropriate primary method (not EV/EBITDA). All figures per Class A common share. Post-convertible-conversion capital structure has stabilized (debt effectively eliminated), but the dilution cost is permanent and already in the current share count.

📊 Capital Structure · Short Interest · Buyback & Dilution

🔴 Short Interest

28.84%

138.14M shares shorted of ~479M outstanding. Very high — reflects skepticism on revenue growth and class action risk. Squeeze potential exists but is contingent on a Q2 beat catalyst.

🔴 Share dilution (1Y)

+65.7%

Shares went from ~289M to 478.95M in 12 months, largely from converting the 2029 convertible notes to equity. Trade-off: eliminated $125M debt overhang but permanently expanded share count.

🔴 Buyback / Dividend

No buyback, no dividend. Capital deployed on R&D, sales/marketing expansion, and paying down the remaining ~$16M convertible tail. Priority is growth investment, not capital return.

Short Interest — context

BBAI — 28.84%

28.84%

The +65.7% share expansion in 12 months is one of the largest in the small-cap AI universe. Balance-sheet repair (debt elimination) is the positive interpretation; permanent equity dilution and consistent capital consumption is the negative. Insider Form 4 flow shows no material open-market insider buying during 2026. Monitor for any post-earnings shelf registration filings.

$Financial analysis — FY 2025 / Q1 2026

Q1 2026 Revenue

$34.4M

Flat YoY (unchanged)

Q1 2026 Gross Margin

34.0%

+1,278 bps YoY (from 21.3%)

Backlog

$281.9M

+14% QoQ · $53M classified prime

Cash & investments

$431.5M

Debt effectively eliminated (~$16M residual)

Item	FY 2023	FY 2024	FY 2025	FY 2026E	Guidance
Revenue ($M)	155	158	158.2	135–165	Reaffirmed
Gross margin % (GAAP)	27%	28%	29%	~35%	Trending higher (mix)
Adj. EBITDA ($M)	−30	−38	−45	~−30	Path to positive H2 2027
Cash ($M, EOP)	33	50	440	~350	Net burn slower post-convert repair
Shares out (M)	~185	~215	289	~479	+65.7% YoY from converts

Notes: FY 2025 revenue was essentially flat vs FY 2024 — despite backlog growth, revenue recognition on the government contracts is slow. Balance sheet transformation in Q1 2026 (convertible elimination) is the biggest structural change; the equity dilution is now baked in.

Quarterly dynamics — last 5 quarters ($M)
Metric	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue ($M)	34.4	36.0	41.5	46.3	34.4
Gross margin % (GAAP)	21.3%	25.1%	27.4%	29.8%	34.0%
Adj. EBITDA ($M)	−1.6	−8.5	−12.2	−22.5	−9.9
End-of-period cash ($M)	81	68	90	440	432

Financial position and sustainability

Cash runway at current burn (~$60M/yr)

~7 years

FY26 revenue growth guidance midpoint

~−5%

Backlog / FY26 revenue (coverage)

~1.9x

Stock YTD 2026 performance

−47.6%

account_tree

Business model — AI-driven defense & national security services

Government AI services with expanding biometrics and GenAI wedges

BigBear.ai is a McLean-based AI/analytics contractor built for U.S. federal customers — Department of Defense, intelligence community (IC), and civilian agencies (NASA, FAA). Three segments: (1) National security analytics and decision-support; (2) Digital identity/biometrics (airport programs at ORD, DFW); (3) Supply chain visibility. Ask Sage GenAI platform is the emerging growth wedge, with wins across NASA, U.S. Army, and Naval Research Laboratory. Revenue is contract-backed with 1.9x backlog coverage of 2026 guidance — visibility is high, but flat FY2024/2025 revenue shows conversion is slow.

National Security & IC ~$75M FY26E (~50% rev) 🟢 backlog growing Prime contracts with DoD and intelligence agencies. $53M sole-source classified win in Q1 anchors 2026-27 revenue. Sticky multi-year contracts, GM 35-40%. Digital Identity / Biometrics ~$40M FY26E (~27% rev) 🟢 airport wins Airport biometrics (Chicago O'Hare + Dallas/Fort Worth deployments $7M in Q1). TSA-adjacent tailwind. Longer sales cycles but real capacity ramp. Ask Sage GenAI + Supply Chain ~$35M FY26E (~23% rev) 🟡 emerging Ask Sage GenAI platform for federal use. Multiple wins (NASA, Army, NRL). Highest-margin segment but smallest; core option value if it scales.

gavel

Legal, regulatory and risk analysis

Securities class action (2029 Convertible restatement)

Critical

Levi & Korsinsky (Apr 11, 2025), Rosen, Robbins LLP, Kessler Topaz all filed/investigating. Class period Mar 31, 2022 – Mar 25, 2025. Material accounting error in 2029 Convertible Notes, restated 10-K FY2024. Realistic settlement $15-50M.

Flat revenue growth trajectory

High

FY 2023 → FY 2025 revenue essentially flat (~$155-158M). Q1 2026 revenue $34.4M unchanged YoY. Backlog conversion is slow; without acceleration, the growth thesis erodes.

Q2 2026 earnings binary (July 30)

High

Tomorrow's print is a hard binary. Consensus $36.4M / EPS −$0.04. Beat/raise triggers squeeze on 28.84% SI; miss/cut compounds bear scenario. Small-cap defense-AI names have shown ±20% single-day moves on earnings historically.

Government contract concentration

Moderate

Highly dependent on DoD/IC/civilian federal budgets. Any budget continuing resolution, program cancellation, or awarded protest can delay recognized revenue. TS/SCI clearance environment adds friction.

Mega-cap AI competition (Palantir, C3, etc.)

Moderate

Palantir dominates the government-AI narrative; BBAI competes as the small-scale alternative. Positioning risk if agencies consolidate spending on incumbents.

Cash-rich balance sheet

Positive

$431M cash + $16M residual debt = ~$415M net cash on a ~$1.34B market cap (~31% of market cap in cash). Removes near-term equity raise pressure. Long runway (~7 years at current burn).

Backlog visibility

Positive

$281.9M backlog = ~1.9x FY26 revenue midpoint. +14% QoQ growth. $53M classified sole-source award anchors 2026-27 pipeline. Higher visibility than most small-cap AI peers.

Defense-AI secular tailwind

Positive

DoD budget FY2026 emphasizes AI-driven decision support, biometrics, and supply chain visibility — all core BBAI competencies. Sector-level demand supports multi-year backlog conversion.

article

SWOT analysis

Strengths

+$281.9M backlog (+14% QoQ), 1.9x coverage of FY26 revenue
+$431M cash + zero effective debt post-convertible conversion
+Gross margin expanded +1,278 bps YoY in Q1 (21% → 34%)
+Real DoD/IC/NASA/Army/NRL contract wins — not vaporware
+Ask Sage GenAI platform provides federal AI monetization wedge

Weaknesses

−Revenue flat FY23-25 (~$155-158M) — growth thesis unproven at scale
−Adj. EBITDA still negative and worsening in Q1 (−$9.9M)
−Share count +65.7% YoY — permanent equity dilution
−Restated 10-K, material accounting weakness disclosed
−No history of positive FCF, no capital return

Opportunities

→Q2 beat + guide raise could trigger 28.84% SI squeeze
→Ask Sage adoption at additional federal agencies
→DoD FY2027 budget expected to emphasize AI/autonomy
→Airport biometrics expansion beyond ORD/DFW pilots
→M&A tuck-in candidate (small-cap defense AI consolidation)

Threats

!Q2 miss compounds YTD −47.6% decline
!Class action settlement drag on earnings + narrative
!Palantir/mega-cap AI displacing sub-scale AI vendors
!Federal budget continuing resolution delaying contract awards
!Further equity raise if burn re-accelerates

article

Summary by assessment area

🟢 Balance sheet — Repaired

$431M cash + <$17M debt = ~$415M net cash
~31% of market cap in cash — strong floor
Convertible debt overhang eliminated Q1 2026
~7 years runway at current burn

🟡 Growth & execution — Uncertain

Revenue flat 2023-2025, Q1 2026 flat YoY
But backlog +14% QoQ = leading indicator
GM expansion +1,278 bps is real quality signal
Q2 earnings (July 30) is the immediate test

🔴 Governance & legal — Elevated

Active class action on convertible restatement
Material accounting weakness disclosed
+65.7% share dilution in 12 months
Short interest 28.84% reflects fundamental doubt

Sources & Disclaimer

Sources: SEC 8-K filings (BigBear.ai, 2025-2026), Q1 2026 earnings release & call transcript (May 5, 2026), IR press releases (bigbear.ai/newsroom), Stockanalysis.com, Yahoo Finance, Investing.com, CNN Markets, MarketBeat, The Motley Fool, BigGo Finance, StockTitan, TipRanks, Fintel (short interest), Levi & Korsinsky / Rosen Law / Robbins LLP / Kessler Topaz class-action notices. Market data — intraday snapshot 2026-07-29: BBAI ~$2.80 (day range $2.67–$2.87; prior close $2.83 on 2026-07-28), market cap ~$1.34B, 52W range $2.67–$9.39, ~478.95M shares outstanding, cash $431.5M, residual debt ~$16.5M. Short interest 28.84% (~138M shares). Q1 2026: revenue $34.4M (flat YoY), GM 34.0%, adj. EBITDA −$9.9M, backlog $281.9M (+14% QoQ). Q2 2026 earnings release scheduled 2026-07-30. Peer set: AI (C3.ai), SOUN (SoundHound), PLTR (Palantir — reference outlier). This document is for informational purposes only and does not constitute financial or investment advice.